Understanding Late Stage Trials Immunotherapy Combinations For Nsclc
If you are looking for information about Late Stage Trials Immunotherapy Combinations For Nsclc, you have come to the right place. Panelists Mark A. Socinski, MD; David R. Spigel, MD; Ross Camidge, MD, PhD; Jared Weiss, MD; and Mark G. Kris, MD, comment ...
Key Takeaways about Late Stage Trials Immunotherapy Combinations For Nsclc
- Jay Lee, MD, University of California, Los Angeles, CA, discusses the role of
- Dr Marina Garassino speaks to ecancer at ESMO 2019 in Barcelona commenting on the CheckMate-227
- Immunotherapy
- Learn about a clinical
- Dr Roy Herbst speaks to ecancer about the results of a
Detailed Analysis of Late Stage Trials Immunotherapy Combinations For Nsclc
Roy S. Herbst, MD, PhD, and Vassiliki A. Papadimitrakopoulou, MD, provide perspective on Panelists Mark A. Socinski, MD; Jared Weiss, MD; David R. Spigel, MD; Mark G. Kris, MD; and Ross Camidge, MD, PhD, discuss ... Join Drs. Narjust Duma, Julian Molina, and Eric Edell as they discuss the importance of a multidisciplinary tumor board for optimal ...
Co-Chairs, Nasser Altorki, MD, and Jonathan D. Spicer, MD, PhD, FRCSC, discuss
We hope this detailed breakdown of Late Stage Trials Immunotherapy Combinations For Nsclc was helpful.
